公司概覽
業務類別 Biotechnology
業務概覽 Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
公司地址 c/o Biohaven Pharmaceuticals, Inc, 215 Church Street, New Haven, CT, USA, 06510
電話號碼 +1 203 404-0410
傳真號碼 --
公司網頁 https://www.biohaven.com
員工數量 274
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. William B.J. Jones, M.D. Chief Commercial Officer, Migraine and Common Diseases 美元 507.15K 11/03/2022
Mr. Bruce Car Chief Scientific Officer 美元 515.57K 18/03/2025
Ms. Kimberly Gentile Senior Vice President, Clinical Operations 美元 489.31K 18/03/2025
Mr. Charles Conway Chief Scientific Officer -- 11/03/2022
Dr. Vlad Coric, M.D. Chief Executive Officer and Chairman of the Board 美元 885.00K 02/03/2026
Mr. George C. Clark Chief Accounting Officer and Vice President -- 02/03/2026
Mr. Matthew Buten Chief Financial Officer 美元 573.30K 02/03/2026
 
董事會成員
董事會 職務 更新日期
Ms. Julia P. Gregory Independent Director 02/03/2026
Dr. Gregory Hugh Bailey, M.D. Independent Director 02/03/2026
Mr. Robert J. Hugin Independent Director 02/03/2026
Mr. Michael T. Heffernan, R.Ph. Lead Independent Director 02/03/2026
Mr. John W. Childs Independent Director 02/03/2026
Dr. Vlad Coric, M.D. Chief Executive Officer and Chairman of the Board 02/03/2026
Mr. Michael Hefferenan Director 25/02/2022
Mr. Kishan Mehta Director 02/03/2026
Dr. Irina Antonijevic, M.D.,PhD Independent Director 02/03/2026
 
所屬ETF (更新日期: 07/03/2026 04:09)
代號 名稱 佔比% 持有日期
BBCVirtus LifeSci Biotech Clinical Trls ETF0.02%27/02/2026
ISCGiShares Morningstar Small-Cap Growth ETF0.01%28/02/2026
ESGVVanguard ESG US Stock ETF0.01%31/01/2026
ISCViShares Morningstar Small-Cap Value ETF0.01%28/02/2026
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
WSMLiShares MSCI World Small-Cap ETF0.005%28/02/2026
IBRNiShares Neuroscience and Healthcare ETF0.005%28/02/2026
UWMProShares Ultra Russell20000.004%27/02/2026
URTYProShares UltraPro Russell20000.004%27/02/2026
TILTFlexShares Mstar US Mkt Factors Tilt ETF0.004%27/02/2026
ISCBiShares Morningstar Small-Cap ETF0.003%28/02/2026
ITWOProShares Russell 2000 High Income ETF0.003%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.002%28/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.001%27/02/2026
TNXTT. Rowe Price Innovation Leaders ETF0.0005%28/02/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0004%31/05/2023
KBFRInnovator U.S. Small Cap Mgd 10 Bfr ETF0.0003%27/02/2026
WDNAWisdomTree BioRevolution ETF0.0002%27/02/2026
AVUQAvantis U.S. Quality ETF0.0002%28/02/2026
HDGProShares Hedge Replication0.0001%27/02/2026
  1   2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.